Search Results - Najmi, Nooshin

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Lateral Thinking: The Lateral Arm Approach for Stereotactic-Guided Breast Biopsies. What We’ve Learned So Far

    Lateral Thinking: The Lateral Arm Approach for Stereotactic-Guided Breast Biopsies. What We’ve Learned So Far by Najmi, Nooshin, Rashid, Mollie A., Fardanesh, Reza, Fischer, Cheryce P.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Diagnostic accuracy of ultrasonic examination in suspected craniosynostosis among infants

    Diagnostic accuracy of ultrasonic examination in suspected craniosynostosis among infants by Alizadeh, Houman, Najmi, Neda, Mehdizade, Mehrzad, Najmi, Nooshin

    Published in Indian pediatrics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Diagnostic Accuracy of Ultrasonic Examination in Suspected CraniosynostosisAmong Infants

    Diagnostic Accuracy of Ultrasonic Examination in Suspected CraniosynostosisAmong Infants by Alizadeh, Houman, Najmi, Neda, Mehdizade, Mehrzad, Najmi, Nooshin

    Published in Indian pediatrics
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract CT205: Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, PD-1 antibody x IL-21 mutein bifunctional fusion protein, in patients with advanced solid tumors

    Abstract CT205: Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, PD-1 antibody x IL-21 mutein bifunctional fusion protein, in patients with advanced s... by Durm, Greg, Frentzas, Sophia, Rasmussen, Erik, Najmi, Saltanat, Sadraei, Nooshin Hashemi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    417 Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, IL-21 receptor agonist and anti-PD-1 antibody, in patients with advanced solid tumors

    417 Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, IL-21 receptor agonist and anti-PD-1 antibody, in patients with advanced solid tumors by Durm, Gregory, Frentzas, Sophia, Rasmussen, Erik, Najmi, Saltanat, Sadraei, Nooshin

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    403 Early results from a phase 1 study to evaluate safety, pharmacokinetics, and efficacy of AMG 404, a programmed death-1 (PD-1) antibody, in patients with advanced solid tumors

    403 Early results from a phase 1 study to evaluate safety, pharmacokinetics, and efficacy of AMG 404, a programmed death-1 (PD-1) antibody, in patients with advanced solid tumors by Price, Timothy, Chawla, Sant, Falchook, Gerald, Prenen, Hans, Lugowska, Iwona, Subbiah, Vivek, Monzon, Jose, Ozawa, Yuichi, Arkenau, Tobias, Caio Rocha Lima, Kuboki, Yasutoshi, Nishina, Tomohiro, Mun, Hui, Rasmussen, Erik, Hansen, Wong, Najmi, Saltanat, Sadraei, Nooshin

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: